Usefulness of preoperative FDG-PET for detection of gastric cancer

BackgroundPositron emission tomography (PET), using 18F-fluoro-2-deoxy-d-glucose (FDG) as a tracer, can detect malignant neoplasms with altered glucose metabolism. To clarify the usefulness of FDG-PET for detecting gastric cancer, we evaluated preoperative PET imaging in gastric cancer patients.MethodsSixty-two gastric cancer patients who underwent FDG-PET imaging and gastric resection with lymphadenectomy were evaluated.ResultsFor primary tumor assessment by PET, detection rates were significantly different in the following order: tumor size 30 mm or more (76.7%) > tumor size less than 30 mm (16.8%); advanced gastric cancer (AGC, 82.9%) > early gastric cancer (EGC; 25.9%); with nodal involvement (79.3%) > without nodal involvement (39.4%). In EGCs, the detection rate of the intestinal type, according to Lauren's classification (43.8%) was significantly higher than that of the diffuse type (0%). Two of the 7 EGC patients who were PET-positive had nodal involvement and their tumors were the intestinal type. For the assessment of nodal involvement, the accuracy of nodal involvement detection was 67.7% with PET and 75.8% with computed tomography (CT). Preoperative FDG-PET revealed colon cancer in 2 patients, adrenal tumor in 1 patient, lung cancer in 1 patient, and lung metastasis in 1 patient.ConclusionLarger or more advanced tumors with nodal involvement had a higher detection rate by PET. In EGCs, only the intestinal type was detectable by PET. PET-positive EGC may be aggressive, and an adequate lymphadenectomy must be done. Preoperative PET was useful for the detection of other malignancies and distant metastasis.

[1]  S. Larson,et al.  Accuracy of FDG-PET in Gastric Cancer. Preliminary Experience. , 1998, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

[2]  M. Sasaki,et al.  An analysis of the physiological FDG uptake pattern in the stomach , 2003, Annals of nuclear medicine.

[3]  T. Sugino,et al.  Expression of glucose transporter‐1 in human gastric carcinoma , 2001, Cancer.

[4]  H. Groen,et al.  Preoperative staging of non-small-cell lung cancer with positron-emission tomography. , 2000, The New England journal of medicine.

[5]  P. V. van Rijk,et al.  Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography. , 2000, Annals of surgery.

[6]  Japanese Gastric Cancer Association Japanese Classification of Gastric Carcinoma – 2nd English Edition – , 1998, Gastric Cancer.

[7]  K. Ishiwata,et al.  Tracer feasibility for monitoring tumor radiotherapy: a quadruple tracer study with fluorine-18-fluorodeoxyglucose or fluorine-18-fluorodeoxyuridine, L-[methyl-14C]methionine, [6-3H]thymidine, and gallium-67. , 1991, Journal of Nuclear Medicine.

[8]  W. Walters TUMORS OF THE STOMACH , 1933, Annals of surgery.

[9]  Woo Jin Hyung,et al.  Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography , 2005, Cancer.

[10]  H. Katoh,et al.  Evaluation of 18F-2-deoxy-2-fluoro-d-glucose Positron Emission Tomography for Gastric Cancer , 2004, World Journal of Surgery.

[11]  P. Dupont,et al.  Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  H. Fukuda,et al.  Comparison of intratumoral distribution of 99mTc-MIBI and deoxyglucose in mouse breast cancer models. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  M. Schwaiger,et al.  FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  P. Flamen Positron emission tomography in colorectal cancer. , 2002, Best practice & research. Clinical gastroenterology.